194 related articles for article (PubMed ID: 19956906)
1. Insulin-like growth factor binding proteins-2 and -4 enhance the migration of human CD34-/CD133+ hematopoietic stem and progenitor cells.
Bartling B; Koch A; Simm A; Scheubel R; Silber RE; Santos AN
Int J Mol Med; 2010 Jan; 25(1):89-96. PubMed ID: 19956906
[TBL] [Abstract][Full Text] [Related]
2. Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells.
Chen Q; Khoury M; Limmon G; Choolani M; Chan JK; Chen J
Stem Cells; 2013 Jun; 31(6):1160-9. PubMed ID: 23404852
[TBL] [Abstract][Full Text] [Related]
3. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.
Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM
Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines.
Noll K; Wegmann BR; Havemann K; Jaques G
J Clin Endocrinol Metab; 1996 Jul; 81(7):2653-62. PubMed ID: 8675593
[TBL] [Abstract][Full Text] [Related]
5. Human placenta-derived Wnt-5a induces the expression of ICAM-1 and VCAM-1 in CD133(+)CD34(+)-hematopoietic progenitor cells.
Herr F; Horndasch M; Howe D; Baal N; Goyal P; Fischer S; Zygmunt M; Preissner KT
Reprod Biol; 2014 Dec; 14(4):262-75. PubMed ID: 25454492
[TBL] [Abstract][Full Text] [Related]
6. Control of AC133/CD133 and impact on human hematopoietic progenitor cells through nucleolin.
Bhatia S; Reister S; Mahotka C; Meisel R; Borkhardt A; Grinstein E
Leukemia; 2015 Nov; 29(11):2208-20. PubMed ID: 26183533
[TBL] [Abstract][Full Text] [Related]
7. The neurotransmitter GABA is a potent inhibitor of the stromal cell-derived factor-1alpha induced migration of adult CD133+ hematopoietic stem and progenitor cells.
Seidel J; Niggemann B; Punzel M; Fischer J; Zänker KS; Dittmar T
Stem Cells Dev; 2007 Oct; 16(5):827-36. PubMed ID: 17999603
[TBL] [Abstract][Full Text] [Related]
8. Circulating CD34+ progenitor cells modulate host angiogenesis and inflammation in vivo.
Popa ER; Harmsen MC; Tio RA; van der Strate BW; Brouwer LA; Schipper M; Koerts J; De Jongste MJ; Hazenberg A; Hendriks M; van Luyn MJ
J Mol Cell Cardiol; 2006 Jul; 41(1):86-96. PubMed ID: 16780869
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic, Morphological and Adhesive Differences of Human Hematopoietic Progenitor Cells Cultured on Murine versus Human Mesenchymal Stromal Cells.
Reichert D; Friedrichs J; Ritter S; Käubler T; Werner C; Bornhäuser M; Corbeil D
Sci Rep; 2015 Oct; 5():15680. PubMed ID: 26498381
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells.
Price WA; Moats-Staats BM; Stiles AD
Am J Respir Cell Mol Biol; 1995 Oct; 13(4):466-76. PubMed ID: 7546777
[TBL] [Abstract][Full Text] [Related]
11. Circulating CD133+ CD34+ progenitor cells and plasma stromal-derived factor-1alpha: predictive role in ischemic stroke patients.
Chen Y; Lu B; Wang J; Chen S; Lin Z; Ma X; Liu Y; Zhao B; Chen Y
J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):319-26. PubMed ID: 25444027
[TBL] [Abstract][Full Text] [Related]
12. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
[TBL] [Abstract][Full Text] [Related]
13. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
[TBL] [Abstract][Full Text] [Related]
14. The frequency of multipotent CD133(+)CD45RA(-)CD34(+) hematopoietic stem cells is not increased in fetal liver compared with adult stem cell sources.
Radtke S; Haworth KG; Kiem HP
Exp Hematol; 2016 Jun; 44(6):502-7. PubMed ID: 27016273
[TBL] [Abstract][Full Text] [Related]
15. The mouse intraovarian insulin-like growth factor I system: departures from the rat paradigm.
Adashi EY; Resnick CE; Payne DW; Rosenfeld RG; Matsumoto T; Hunter MK; Gargosky SE; Zhou J; Bondy CA
Endocrinology; 1997 Sep; 138(9):3881-90. PubMed ID: 9275078
[TBL] [Abstract][Full Text] [Related]
16. Growth regulation via insulin-like growth factor binding protein-4 and -2 in association with mutant K-ras in lung epithelia.
Sato H; Yazawa T; Suzuki T; Shimoyamada H; Okudela K; Ikeda M; Hamada K; Yamada-Okabe H; Yao M; Kubota Y; Takahashi T; Kamma H; Kitamura H
Am J Pathol; 2006 Nov; 169(5):1550-66. PubMed ID: 17071580
[TBL] [Abstract][Full Text] [Related]
17. Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells.
Bissels U; Wild S; Tomiuk S; Hafner M; Scheel H; Mihailovic A; Choi YH; Tuschl T; Bosio A
Stem Cells; 2011 May; 29(5):847-57. PubMed ID: 21394831
[TBL] [Abstract][Full Text] [Related]
18. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
[TBL] [Abstract][Full Text] [Related]
19. Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood.
Lazarova P; Wu Q; Kvalheim G; Suo Z; Haakenstad KW; Metodiev K; Nesland JM
Int J Immunopathol Pharmacol; 2006; 19(1):49-56. PubMed ID: 16569339
[TBL] [Abstract][Full Text] [Related]
20. Biology and plasticity of CD133+ hematopoietic stem cells.
Handgretinger R; Gordon PR; Leimig T; Chen X; Buhring HJ; Niethammer D; Kuci S
Ann N Y Acad Sci; 2003 May; 996():141-51. PubMed ID: 12799292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
